Pharma

UK-based healthcare investor, Atlas Health Capital, has agreed to acquire AGB-Pharma, an independent, Swedish, family-owned, pharmaceutical company that focuses on sleep health and specialises...

Fresenius, a Germany-based global, therapy-focused healthcare company, is expanding its access to innovation networks through Fresenius Ventures, its own corporate venture capital fund that...

Listed South Korean CDMO, Samsung Biologics, is acquiring all shares in SIX-listed PolyPeptide, a specialised CDMO for peptide-based active pharmaceutical ingredients, for CHF44.31 per...

Germany-based healthcare investor SHS Capital is acquiring a majority stake in Basic Pharma, a Dutch speciality pharmaceutical platform and full-service CDMO, providing a succession...

France-based global healthcare investor has completed the take private of Esperion Therapeutics, a US-based, commercial-stage biopharmaceutical company bringing innovative cardiometabolic and rare/orphan disease therapies...

Despite geopolitical uncertainty and subdued M&A markets, healthcare remains one of the most attractive sectors for private equity investment, according to Rothschild & Co's...

Asset-light pharma services are entering a new era as pharmaceutical companies grapple with increasingly complex regulatory, commercial and technological challenges. Although growth in pharma...

Mérieux Equity Partners has held a first close of its new healthcare‑dedicated buyout fund, Mérieux Participations 5 (MP5), at €335m out of a €600m...

Jeito Capital, a France-based private equity firm dedicated to Biopharma, has appointed of a new partner, Magdalena Jonikas, and a principal, Anastasiya Sybirna, to...

CVC Capital Partners has announced the final close of CVC Capital Partners Catalyst III, its European-focused mid-market private equity fund, at approximately €3.0bn (US$3.4bn)...